From: Cost-effectiveness analysis of a state funded programme for control of severe asthma
year before ProAR | year after ProAR | ||
---|---|---|---|
Health care utilization per patient | median (quartiles) | median (quartiles) | p* |
Regular specialist visits | 0 (0/0) | 9 (6/12) | < 0.01 |
Spirometries performed | 1 (0/1) | 2 (2/2) | < 0.01 |
Emergency/unscheduled visits | 36 (6/120) | 1 (0/3) | < 0.01 |
Hospitalizations | 1 (0/2) | 0 (0/0) | < 0.01 |
Quality of life | |||
Total AQLQ score | 2 (2/3) | 4 (3/6) | < 0.01 |
Asthma control | |||
ACQ scores | 4 (3/5) | 2 (0.6/3) | < 0.01 |
% of expected FEV1 | 69 (49/82) | 76 (58/84) | 0.560 |
% of expected PEF | 45 (34/66) | 66 (49/83) | < 0.01 |